The Bureau of Justice Assistance (BJA) and the National Institute of Corrections (NIC) recently published the Guidelines for Managing Substance Withdrawal in Jails: A Tool for Local Government Officials, Jail Administrators, Correctional Officers, and Health Care Professionals. The document provides guidelines for jail professionals to manage and care for individuals with substance use disorders (SUDs) who enter their facilities effectively and efficiently. A single set of guidelines allows jail professionals to unite around a shared policy and procedure for responding to individuals at risk for substance withdrawal, whether it’s from alcohol, sedative-hypnotics, opioids, or stimulants.
Local government, jail administrators, correctional officers, and health care professionals play key roles in developing policy and procedures that detect and properly manage substance withdrawal among individuals in jails. By establishing clear guidelines, jail staff can save lives and promote the well-being of adults who are at risk for SUDs and withdrawal.
Withdrawal Management Process
Custody and health care staff are the foundation for an effective withdrawal management process. These individuals should be conducting regular and active observation that begins the moment an individual arrives at the jail. All individuals should be screened for risk of withdrawal, regardless of their length of stay in the jail. Screening helps to identify individuals who:
• need immediate clinical assessment,
• have used alcohol or sedatives recently, regularly, and/or heavily,
• have a history of complicated withdrawal,
• are pregnant and screen positive for alcohol or opioid use.
Should an individual screen positive for withdrawal risk, they then move onto the next stage of the withdrawal management process: the clinical assessment. The initial clinical assessment addresses whether swift action is needed to avoid critical biomedical or psychiatric issues due to withdrawal. The results of the clinical assessment will determine whether an individual’s needs can be addressed and care for within the jail or if they must transfer to a higher level of care.
Different jails have different levels of health care capacity. A larger jail with more staff has greater access to resources than a smaller jail would. In this case, jail administrators must consider whether onsite withdrawal management or external transfer is best for the patient. If onsite withdrawal management is appropriate, the treating clinician will provide specific guidance for ongoing monitoring and care during withdrawal. Custody staff who are trained or qualified health care staff may monitor vital signs and assess withdrawal symptoms. If the jail does not have the capacity to manage the patient safely and effectively during the withdrawal process, the patient should be transferred to a higher level of care.
Screening for Withdrawal Risk
Several factors contribute to withdrawal symptoms and severity, including duration, usage, prior episodes of withdrawal, and the presence of other medical conditions. These conditions will influence the severity of withdrawal, which is why screening is critical for identifying those who are at risk for withdrawal so staff can take the appropriate measures. Screening tools are used to gauge risk for withdrawal and identify those who should be monitored by correctional staff and those who should be referred for immediate clinical assessment. Screening usually includes documenting what type of substance the individual used, routes of use, amount used, frequency and recency of use, and any prior withdrawal history.
Additionally, screening allows custody staff to address whether the patient must continue using prescribed medications without suffering from withdrawal. If staff can verify the prescription within twenty-four hours, the medication should be continued. During the verification process, the patient should be monitored for withdrawal signs and symptoms and then administer their prescribed medication.
Prescription medications can be verified through prescribers, pharmacies, and community databases. The Prescription Drug Monitoring Program (PDMP) tracks controlled substance prescriptions. However, methadone prescriptions usually cannot be verified through the PDMP.
Monitoring for Signs and Symptoms
When an individual screens positive for substance withdrawal risk, they must be monitored for the emergence of withdrawal indicators. These indicators include:
• agitation
• severe depression/individual withdraws
• dilated pupils
• incoherent speech
• increased anxiety/panic
• paranoia
• audio/visual hallucinations
• seeming unaware of who/where they are
• seizures
• suicidal behavior
• diarrhea
• tremors
• vital signs outside of the normal range
• vomiting
Monitoring for Signs and Symptoms
Table 1 outlines possible indicators of alcohol, sedative, opioid, and stimulant withdrawal.
Staff must remain alert and attentive to any changes in behavior or indicator that an individual is unwell. The person in custody may not be able to report what they have ingested due to possible unknown contamination with another substance.
Staffing and Staff Training
Building a sense of teamwork between custody and health care staff is crucial to provide a unified response to substance use withdrawal. Jail administrators must set clear policies and protocols regarding the roles of custody and health care staff in managing substance withdrawal. As such, staff must be trained in their roles and responsibilities regarding substance withdrawal. It is not within the purview of custody staff to diagnose the cause of signs and symptoms.
Jails that do not have expertise in substance use withdrawal, withdrawal management, or overdose risk should establish relationships with local experts, which may include local public health organizations and state substance use treatment institutions. Jails should have a twenty-four hour, on-call clinical support staff or individual. Jail administrators may consider remote coverage, telehealth services, onsite health care staff, or a combination. Further, while it is not the responsibility of custody staff to diagnose symptoms, they should be trained to identify when a patient appears "unwell" to a lay observer to make an immediate referral to medical staff.
Custody staff may be trained to screen for withdrawal risk and follow the established protocols to ensure patients at risk for withdrawal receive the necessary medical services. If need be, custody staff may be trained to administer withdrawal severity tools, which may include observing and collecting vital signs and coordinating with on-call medical staff when health care staff are not available. Custody staff who conduct screenings or administer withdrawal severity tools should be trained by a qualified health care professional. Any staff that conducts these screenings should be assessed yearly to ensure competence, safety, and reduce liability. The assessments should ensure that staff is able to address misconceptions and stigma surrounding SUD, treatment, and the medications that can be used to treat OUD. Refer to Table 2 to identify what action custody and health care staff should take after a clinical assessment.
Reentry
Reentering the community can be a challenging time for any inmate, especially those facing substance use withdrawal. Reentry plans should be individualized based on the patient’s ongoing need for managing withdrawal, and includes treatment engagement, overdose prevention, and recovery support. These plans should include:
• Assertive referrals
• Sharing health records as authorized by state law
• Establishing insurance coverage
• Provide information on where individuals can follow up in the community upon release to obtain withdrawal management treatment services
• Where possible, provide medication to sustain the individual until their next appointment
Conclusion
A unified approach to addressing, screening, and treating substance use withdrawal and opioid use disorders are critical in ensuring an equal level of treatment and reducing recidivism upon an individual’s reentry into the community. For more information on the guidelines for managing specific substance use withdrawal, refer to the Guidelines for Managing Substance Withdrawal in Jails: A Tool for Local Government Officials, Jail Administrators, Correctional Officers, and Health Care Professionalsas provided by the BJA and NIC. Further, the BJA’s Comprehensive Opioid, Stimulant, and Substance Use Program’s (COSSUP) Jail Resources provide multiple resources for jails seeking to implement the guidelines in their facilities, including why and how the guidelines were developed and its methodology, a fact sheet providing an overview of the guideline, awareness-building videos, and curated resources from experts.
______________________________
Madyson Bracken is the Communications and Publications Manager of the American Jail Association and a freelance writer. She graduated from Shippensburg University with a Bachelor’s in Communication and Journalism, emphasizing in electronic media. She has experience as a ghostwriter, radio host, social media manager, and photographer. She can be contacted at madysonb@aja.org.
References
Solomon, A.L., Moore, K. F., & McLearen, A. M. (2023, June). Guidelines for Managing
Substance Withdrawal in Jails: A Tool for Local Government Officials, Jail Administrators, Correctional Officers, and Health Care Professionals. Washington, D.C.; Bureau of Justice Assistance, Washington, D.C.; National Institute of Corrections.